Business
Currency:USD
2023/Q3
Stock NameRevenueRatio
Central Nervous System19.31M23.99%
Other13.34M16.57%
Cardiovascular13.06M16.22%
Gastrointestinal9.93M12.34%
Endocrinology8.07M10.02%
Contract manufacturing revenue5.4M6.71%
Other3.06M3.80%
Infectious Disease2.83M3.51%
Migraine2.77M3.44%
Analgesic2.74M3.40%
View all
Region
Currency:USD
2022/FY
Stock NameRevenueRatio
United States340.58M100.00%
